Till startsida
To content Read more about how we use cookies on gu.se

Key Publications

Olofsson Bagge R, Carlson P, Razzazian R, Hansson C, Hjärpe A, Mattsson J, Katsarelias D. Minimally invasive isolated limb perfusion - technical details and initial outcome of a new treatment method for limb malignancies. Int J Hyperthermia. 2018 Nov 14:1-7

Johansson J, Kiffin R, Andersson A, Lindnér P, Naredi P, Olofsson Bagge R, Martner A. Isolated limb perfusion with melphalan triggers immune activation in melanoma patients. Frontiers in Oncology.

Olofsson Bagge R, Akif Demir, Joakim Karlsson, Babak Alaei-Mahabadi, Berglind O. Einarsdottir, Henrik Jespersen Mattias F. Lindberg Andreas Muth, Lisa M. Nilsson Marta Persson Johanna B. Svensson Elin M.V. Söderberg Ronald R. de Krijger Ola Nilsson, Erik Larsson Göran Stenman Jonas A. Nilsson. Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary. JCO Precision Oncology.

Katsarelias D, Rådbo E, Ben-Shabat I, Mattsson J, Olofsson Bagge R. The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion. Ann Surg Oncol. 2018 May 15

Muralidharan SV, Einarsdottir BO, Bhadury J, Lindberg MF, Wu J, Campeau E, Olofsson Bagge R, Stierner U, Ny L, Nilsson LM, Nilsson JA. BET bromodomain inhibitors synergize with ATR inhibitors in melanoma in melanoma. Cell Death Dis. 2017 Aug 10;8(8)

Olofsson Bagge R, Ny L. Adjuvant therapies for malignant melanoma. Br J Surg. 2016 Aug;103(9):1095-6.

Ben-Shabat I, Belgrano V, Ny L, Nilsson J, Lindnér P, Olofsson Bagge R. Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion. Ann Surg Oncol. 2016 Apr;23(4):1327-34

Dossett L, Ben-Shabat I, Olofsson Bagge R, Zager J. Clinical response and regional toxicity following isolated limb infusion compared to isolated limb perfusion for in-transit melanoma. Ann Surg Oncol. 2016 Feb 11.

Lindqvist Bagge AS, Ben-Shabat I, Belgrano I, Olofsson Bagge R. Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion. Ann Surg Oncol. 2016 Feb 11.

Martner A, Johansson J, Ben-Shabat I, Olofsson Bagge R. Melphalan, anti-melanoma immunity and inflammation. Cancer Research. 2015 Dec 15;75(24):5398-9

Ben-Shabat I, Hansson C, Sternby Eilard M, Cahlin C, Rizell M, Lindnér P, Mattsson J, Olofsson Bagge R. Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma. J Vis Exp. 2015 Jan 25;(95):52490

Einarsdottir B, Olofsson Bagge R, Bhadury J, Jespersen H, Mattsson J, Nilsson L, Truvé K, Dávila López M, Naredi P, Nilsson O, Stierner U, Ny L, Nilsson J. Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions. Oncotarget. 2014 Oct 30;5(20):9609-18

Olofsson Bagge R, Cahlin C, All-Ericsson C, Hashimi F, Mattsson J, Rizell M, Lindnér P. Isolated Hepatic Perfusion for Ocular Melanoma Metastasis - Registry Data Suggests a Survival Benefit. Ann Surg Oncol. 2014 Feb;21(2):466-72

Olofsson Bagge R, Lindberg E, Karlsson-Parra A, Lindnér P, Mattsson J, Andersson B. Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: a pilot study in patients with in-transit metastases of malignant melanoma. Int J Hyperthermia. 2013 May;29(3):234-8.

Page Manager: Mattias Lindgren|Last update: 9/16/2019

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?